Q4 2024 Earnings Call Transcript March 12, 2025 biote Corp. beats earnings expectations. Reported EPS is $0.1, expectations ...

Corp. (BTMD) delivered earnings and revenue surprises of 11.11% and 2.85%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

IRVING, Texas--(BUSINESS WIRE)-- Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness ...

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic ...

These updates follow the latest evidence-based medical literature and feature proprietary dosing algorithms that are unique in the marketplace. With these new algorithms, Biote-certified ...

Biote , a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the fourth ...

BioTE Corp (BTMD) reported its fourth-quarter 2024 earnings, revealing a slight miss on earnings per share (EPS) forecasts, which contributed to a negative market reaction. The company posted an ...